已发表论文

心脏代谢标志物与颈动脉粥样硬化关联的评估以及胰岛素抵抗的作用

 

Authors Sun Y, Bai C, Yin S, Liu J

Received 8 May 2025

Accepted for publication 8 August 2025

Published 15 August 2025 Volume 2025:18 Pages 2899—2911

DOI https://doi.org/10.2147/DMSO.S539166

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Rebecca Conway

Yazhao Sun,1 Chunlan Bai,1 Shitong Yin,1 Jianfeng Liu2 

1Department of Cardiology, Cangzhou People’s Hospital, Cangzhou, Hebei, 06100, People’s Republic of China; 2Department of Endocrinology and Metabolism, Cangzhou People’s Hospital, Cangzhou, Hebei, 06100, People’s Republic of China

Correspondence: Jianfeng Liu, Email liujianfeng5500@163.com

Background: Obesity is a growing global health concern. The cardiometabolic index (CMI), a novel marker of fat distribution, has been proposed as a potential risk indicator. This study investigates the association between CMI and carotid atherosclerosis (CAS), as assessed by carotid intima-media thickness (cIMT), and explores whether insulin resistance (IR) mediates this relationship.
Methods: This cross-sectional study enrolled type 2 diabetes mellitus (T2DM) patients hospitalized at Cangzhou People’s Hospital between September 2024 and March 2025. Logistic regression models, restricted cubic spline (RCS) analysis, and subgroup analysis were used to examine the CMI-CAS relationship. The predictive ability of CMI was assessed using receiver operating characteristic (ROC) curves, and its incremental value beyond traditional risk factors was evaluated by integrated discrimination improvement (IDI) and net reclassification improvement (NRI). Mediation analysis assessed the role of IR.
Results: After adjustment, higher CMI was significantly associated with increased odds of CAS (OR = 1.48, 95% CI: 1.21– 1.81, P < 0.001). RCS analysis showed a nonlinear relationship between CMI and CAS. ROC analysis indicated moderate predictive power (AUC = 0.65, 95% CI: 0.61– 0.68). Including CMI improved prediction with an IDI of 0.04 (P < 0.001) and an NRI of 0.26 (P < 0.001). Subgroup analysis revealed a significant interaction with T2DM duration (P = 0.013). Mediation analysis showed that metabolic score for insulin resistance (METS-IR) partially mediated the CMI-CAS relationship, explaining 12.92% of the total effect.
Conclusion: Elevated CMI is independently associated with higher risk of CAS in T2DM patients, and insulin resistance partially mediates this relationship. CMI may be a valuable marker for early vascular risk stratification in diabetic populations.

Keywords: atherosclerosis, carotid intima-media thickness, cardiometabolic index, obesity, insulin resistance